Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Implantica announces that another prominent anti-reflux center has started operating with implantable medical device RefluxStop™

Implantica AG (publ) today announces that Klinikum Friedrichshafen in Germany, one of the largest anti-reflux centers, has begun implementing RefluxStop™. The hospital has successfully completed several surgeries with RefluxStop™ performed by Prof. Dr. med. Lehmann and his team.“We welcome the adoption of the RefluxStop™ surgical procedure by another prominent anti-reflux center and renowned surgeon in Germany, and we look forward to working together with Prof. Dr. med. Lehmann. We anticipate more and more centers to begin with RefluxStop™ as the effects of COVID-19 ease.” said Peter

Incentive’s holding in TietoEVRY exceeds 5%

TietoEVRY Corporation STOCK EXCHANGE RELEASE 7 July 2021 9.30 a.m. EET TietoEVRY Corporation has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Incentive AS. The holding of Incentive exceeded the 5% threshold on 6 July 2021. The holding amounts to 6 082 829 shares, corresponding to a holding of 5.14% in TietoEVRY shares and voting rights. The shares are held by following funds and separately managed accounts: Incentive Active Value Master Fund (a sub-fund of Incentive Investment Funds ICAV) Incentive Active Value Long

BioStock: WntResearch reaches full operations again in NeoFox study

The NeoFox study, conducted to explore the efficacy of WntResearch’s drug candidate Foxy-5, is now back in full swing. A total of 80 patients have been recruited and the company reiterates that it sees good opportunities to obtain an interim result from the study by the end of 2022. BioStock has spoken to Anders Rabbe, CEO of WntResearch, to get his view on the latest news.Read the full article at biostock.se:https://www.biostock.se/en/wntresearch-reaches-full-operations-again-in-neofox-study/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

SynAct Pharma Appoints Anders Dyhr Toft, MD, Ph.D., as Chief Medical Officer

SynAct Pharma AB (“SynAct”) today announced the appointment of Anders Dyhr Toft, MD, PhD, as Chief Medical Officer (CMO), effective August 1, 2021. He will head up clinical development and medical affairs in close collaboration with SynAct’s CSO Dr. Thomas Jonassen. Dr. Toft brings critical experience to the SynAct team as the company advances its lead selective melanocortin asset AP1189 through clinical development.Dr. Toft joins SynAct following almost two decades at Novo Nordisk where he in senior leadership roles in both Medical Affairs, Operations and Commercial has played key roles in

Strong booking trend for First Camp

Business on the books for First Camp, the largest campsite chain in Scandinavia, for July-August is currently 25 percent higher than in 2020, and 13 percent higher than 2019, which was a record year.The camping industry is facing a bright future, thanks to increased domestic vacation. This trend has been accelerated due to Covid-19. Also, retailers report strong sales of caravans and motor caravans. First Camp, with 40 destinations in Sweden and 6 in Denmark, gained market share in 2020. Business on the books for July-August are high, +25 percent vs. 2020 and +13 percent vs. 2019.

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for June 2021

Hamilton, Bermuda, July 7, 2021 Commercial update: In June 2021, the Company achieved average time charter equivalent earnings of approximately US$39,100 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$42,300 per day, gross, including average daily scrubber benefits of approximately US$2,800 per day. The Company’s two vessels trading on fixed time charter earned approximately US$29,700 per day, gross, including average daily scrubber benefits of approximately US$2,300 per day. The Baltic 5TC Capesize Index averaged US$28,533

Adapteo’s first buildings at Fehmarn Belt tunnel are ready for occupation in July

The construction of the Fehmarn Belt tunnel, the world’s longest road-rail tunnel at the bottom of the ocean between Denmark and Germany, has finally begun. Adapteo has been chosen to provide flexible buildings for the 30,000 square metre village FLC Village in Rødbyhavn in Denmark, which is being built to provide thousands of people working with the project with housing, amenities, and recreational spaces. For this purpose, Adapteo has designed totally new buildings and the first ones will be ready for occupation on July 21st.  The EU has named 2021 the “Year of Rail” to highlight the

Finnair Traffic Performance in June 2021

Finnair Plc                   Investor News                   7 July 2021 at 9:00 a.m. EEST Improvement in the passenger traffic figures although the COVID-19 pandemic impact still visible in June, another strong month for cargo In June, Finnair carried 127,900 passengers, which was 131.5% more than in June 2020. The COVID-19 impact was already clearly visible then as Finnair only operated a minimum network due to strict and extensive travel restrictions. The number of passengers in June 2021 was 54.5% more than in May 2021 (month-on-month figures are not fully comparable as there is

Flexion Mobile Plc receives Notice of Allowance from USPTO for its second patent application

LONDON, 7th of July, 2021 –Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company’s patent application no. 16/188,339. This second patent includes 41 claims and provides coverage for additional aspects of Flexion's core technology, relating to methods of modifying an application by modification, addition, and/or removal of machine-readable instructions on target computing platforms at run-time. Flexion provides a unique range of distribution

Strong booking trend for First Camp

Business on the books for First Camp, the largest campsite chain in Scandinavia, for July-August is currently 25 percent higher than in 2020, and 13 percent higher than 2019, which was a record year.The camping industry is facing a bright future, thanks to increased domestic vacation. This trend has been accelerated due to Covid-19. Also, retailers report strong sales of caravans and motor caravans. First Camp, with 40 destinations in Sweden and 6 in Denmark, gained market share in 2020. Business on the books for July-August are high, +25 percent vs. 2020 and +13 percent vs. 2019.

Nordea’s second quarter results 2021 will be presented on Wednesday 21 July 2021

The report will be published at approximately 07.30 EET (06.30 CET). Webcast at 10.30 EET (09.30 CET) Frank Vang-Jensen, President and Group CEO, will present the results followed by a Q&A audio session for investors and analysts with Frank Vang-Jensen, Ian Smith, Group CFO, and Matti Ahokas, Head of Investor Relations. To participate in the webcast, please use the webcast link  or dial one of the following numbers: · +44 333 300 0804 · +46 8 566 426 51 · +358 9 8171 0310 · +45 35 44 55 77 and add confirmation code

Bonava sells 162 rental apartments in Västerås

Bonava has sold 162 Nordic Swan ecolabelled rental apartments in Västerås to the German property investor PATRIZIA AG. The transaction amounts to about SEK 435 million and the first housing units are expected to be completed and handed over to the customer in the fourth quarter of 2023.– Västerås is continuing to grow and there is a major need for more homes. The project has an attractive and central location by Lake Mälaren and the transaction is a confirmation that our offering of high-quality rental housing projects combined with our structured process is creating interest among

Statement from the Board of Directors of Magnolia Bostad in relation to the public tender offer by Holmströmgruppen and Areim

This statement is made by the Board of Directors of Magnolia Bostad AB (publ) ("Magnolia Bostad" or the "Company") pursuant to Section II.19 of Nasdaq Stockholm's Takeover Rules (the "Takeover Rules"). Conclusion The Board[1] unanimously recommends the shareholders of Magnolia Bostad to accept FHH's public tender offer. Background On July 7, 2021, F. Holmström Fastigheter AB ("Holmströmgruppen") and funds or entities managed or advised by Areim AB ("Areim"), through F Holmström Holding 6 AB ("FHH"), made a public tender offer to the shareholders of Magnolia Bostad to tender all

Spermosens appoints an Advisory Board

Spermosens AB (‘Spermosens’) announces today that the company is reinforcing its organization and appointing strategic leading to include industry experts in an Advisory Board.Following a need of assuring the continuous influx of clinical and scientific information in Spermosens’ products, the company is now pleased to introduce its newly appointed Advisory Board. Comprised of Spermosens’ management and scientific experts within the fields of IVF and fertility, the Advisory Board will bring relevant scientific and clinical aspects into discussion, bridging the company and the end users, by

Storytel in line with forecast for Q2 2021

Storytel had an average of 1,626,900 paying subscribers in the second quarter of 2021, which is in line with the forecast of 1,625,000 paying subscribers that was previously estimated. The annual subscriber growth in the second quarter of 2021 was 369,900 customers compared to the second quarter of 2020. Streaming revenues for the second quarter of 2021 came in at 545.5 MSEK which was in line with forecast.The average number of paying Storytel subscribers in the Nordic segment in the second quarter of 2021 was 983,600, which was 1,600 paying subscribers above forecast and corresponds to an

Sobi to present data at the ISTH 2021 within rare haematology diseases

Swedish Orphan Biovitrum AB (publ)  (Sobi™) presents data at the virtual ISTH 2021, the 29th Congress of the International Society on Thrombosis and Haemostasis, 17 – 21 July 2021. Nine abstracts featuring four treatments have been accepted for presentation during ISTH, reflecting Sobi's commitment to the rare disease community within haematology. ISTH gather the world’s leading experts to present recent advances, exchange science and discuss clinical applications designed to improve patient care within haematology. “With the goal of advancing care and providing

Invitation to Stora Enso’s Q2 results webcast on 21 July 2021

STORA ENSO OYJ INVESTOR NEWS 7 July 2021 at 9.00 EESTStora Enso will publish its Interim Report January-June on Wednesday 21 July 2021 at approximately 08.30 Finnish time (07.30 CEST). The following event will take place later that day:Webcast and conference call for analysts, investors and media at 14.00 EESTThe webcast and conference call for analysts, investors and media will take place at 14.00 EEST (13.00 CEST, 12.00 UK time, 07.00 EDT). It will be hosted by President and CEO Annica Bresky, CFO Seppo Parvi, and SVP, Head of Investor Relations Ulla Paajanen, and may be accessed at

SynAct Pharma AB Announces Additional Data from the Phase 2a Trial of AP1189 in Covid-19 Infected Patients and Reminds of Management Call to Discuss Results

SynAct Pharma AB (“SynAct”) today announced additional results from all treated patients in the Phase 2a clinical trial of AP1189 in Covid-19 infected patients with pulmonary insufficiency.  The study was setup with part 1, where all patients were treated with AP1189, and a part 2, a randomized placebo-controlled study testing AP1189 vs placebo, giving a total of 60 treated patients. In this full dataset, AP1189 treated patients achieved respiratory recovery 4 days quicker than placebo treated patients.  A result that was statistically significant.  Management is hosting a conference call on

Holmström Fastigheter Holding’s subsidiary F Holmström Holding 6 AB has today submitted a public offer to the shareholders of Magnolia Bostad

F Holmström Holding 6 AB, reg.no. 559279-7376 (“FHH”), a company which together with inter alia Holmström Fastigheter Holding AB (publ) reg.no. 559286-6809 (“Holmström Holding”) is included in Holmströmgruppen, has today announced a recommended cash offer to the shareholders of Magnolia Bostad AB reg.no. 556797-7078 (“Magnolia Bostad” or “the Company”) to tender all of their shares in Magnolia Bostad to FHH. If the offer is completed, FHH will be controlled by Holmströmgruppen and funds or entities managed and advised by Areim AB reg.no. 556719-4203 ("Areim"). The consideration in the

Sweco to conduct planning for section of the North Bothnia Line

Sweco has been commissioned by the Swedish Transport Administration for the planning of the new section of the North Bothnia Line railway between Norra Tuvan and central Skellefteå. Work is expected to continue until 2031, with a total value of around SEK 200 million.The North Bothnia Line is planned to connect Umeå and Luleå, which entails 270 kilometres of new railway along the Norrland coast in northeastern Sweden. Sweco’s assignment encompasses project planning and the preparation of construction documents for the section from Norra Tuvan to central Skellefteå. “I am very proud that

Read original

TA Associates completes the offer to the shareholders of Elos Medtech AB and thereby becomes the owner of 73.1 per cent of the shares in Elos Medtech AB and extends the acceptance period

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important notice" at the end of

Bravida wins SEK 270 million contract for Stockholm’s new Slussen bus terminal

Bravida has been commissioned by the City of Stockholm to carry out the technical installation work on the new bus terminal that is being built as part of the redevelopment of the Slussen area.Every day, around 400,000 people travel by public transport to or via Slussen. This makes Slussen Sweden's second-largest public-transport hub after T-Centralen. The new Slussen will be adapted to take account of reduced car traffic, with fewer car lanes than at present. More space will be allocated to public transport, as well as pedestrians and cyclists, with new, more attractive quayside routes.

Elekta optimizes treatment times for cancer patients via proactive service innovation

Elekta in the forefront of service innovation through first radiotherapy system availability patentSTOCKHOLM, July 7, 2021 – For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. Among these solutions is the remote exchange of technical system data between Elekta remote service centers and linear accelerators installed at hospitals worldwide. Using Elekta IntelliMax[®] 

There are no items matching the current filter
There are no more items matching the current filter
Back to top